Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Moderna Inc. buy Traumtanz

Moderna Inc.
Start price
€33.80
05.04.20 / 50%
Target price
€40.00
09.04.20
Performance (%)
-12.68%
End price
€29.52
09.04.20
Summary
This prediction ended on 09.04.20 with a price of €29.52. The prediction for Moderna Inc. disappointed with a performance of -12.68%. Traumtanz has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Moderna Inc. 3.276% 3.276% -19.515% -30.996%
iShares Core DAX® 1.051% -1.833% 12.822% 15.392%
iShares Nasdaq 100 -0.547% -3.738% 40.625% 42.396%
iShares Nikkei 225® -1.778% -8.115% 16.092% 0.891%
iShares S&P 500 0.002% -2.226% 28.387% 41.095%

According to Traumtanz what are the pros and cons of Moderna Inc. for the foreseeable future?

Pros
Normal challenges to pay loans and raise capital
Innovative
Some uniques
Differentiated customer and product portfolio
Growths faster than the competition
Sustainability is important
Stable Large shareholder and/or long term investor
Medium risks for its business
Top 10 in its market
Small cyclical dependencies
Known brand
Future proof or reliable business model
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Fair valuation
High dividend yield expected
positive Cash Flow expected
Good rating
Standard Investments for future growth
Valuable balance sheet
ROE higher than 10% per year
Cons

Comments by Traumtanz for this prediction

In the thread Moderna Inc. diskutieren
Prediction Buy
Perf. (%) -12.68%
Target price 40.000
Change
Ends at 09.04.20

Buy mit Kursziel 40,0

Traumtanz 
0
Report Share
05.04.20

ein vielversprechender Chart einer jungen Aktie:
https://en.wikipedia.org/wiki/Moderna
...In January 2020, Moderna announced development of a vaccine to inhibit COVID-19 coronavirus, in competition with other biotechnology companies, such as Gilead Sciences, Vaxart, Inovio Pharmaceuticals, and Novavax. In March 2020, the Phase I human study of the vaccine candidate began in partnership with the US National Institute of Allergy and Infectious Diseases.

Traumtanz 
2
Report Share
05.04.20 Buy -12.68%

https://www.onvista.de/aktien/MODERNA-INC-Aktie-US60770K1079

aber Vorsicht mit der Euphorie von diesen Kriegsgewinnlern...man weiss noch nicht, wer sich hier durchsetzten wird....wenn überhaupt!

Traumtanz 
2
Report Share
05.04.20 Buy -12.68%
In the thread Trading Moderna Inc.
Prediction Buy
Perf. (%) -12.68%
Target price 40.000
Change
Ends at 09.04.20

Buy beendet

Traumtanz 
0
Report Share
09.04.20

Stopped prediction by Traumtanz for Moderna Inc.

buy
Moderna Inc.

Start price
Target price
Perf. (%)
€73.21
02.12.23
€74.00
02.12.24
15.01%
14.12.23

Normal challenges to pay loans and raise capital
Innovative
Some uniques
Differentiated customer and product portfolio
Traumtanz 
02.12.23 50%
sell
Moderna Inc.

Start price
Target price
Perf. (%)
€71.59
24.11.23
€70.00
24.11.24
2.26%
02.12.23

Normal challenges to pay loans and raise capital
Innovative
Some uniques
Differentiated customer and product portfolio
Traumtanz 
24.11.23 50%
buy
Moderna Inc.

Start price
Target price
Perf. (%)
€70.95
23.11.23
€74.00
23.11.24
0.90%
24.11.23

Normal challenges to pay loans and raise capital
Innovative
Some uniques
Differentiated customer and product portfolio
Traumtanz 
23.11.23 50%
sell
Moderna Inc.

Start price
Target price
Perf. (%)
€70.63
21.11.23
€74.00
21.11.24
0.45%
23.11.23

Normal challenges to pay loans and raise capital
Innovative
Some uniques
Differentiated customer and product portfolio
Traumtanz 
21.11.23 50%
buy
Moderna Inc.

Start price
Target price
Perf. (%)
€72.57
20.11.23
€74.00
20.11.24
-2.67%
21.11.23

Normal challenges to pay loans and raise capital
Innovative
Some uniques
Differentiated customer and product portfolio
Traumtanz 
20.11.23 50%
buy
Moderna Inc.

Start price
Target price
Perf. (%)
€69.64
31.10.23
€71.00
31.10.24
4.21%
20.11.23

Normal challenges to pay loans and raise capital
Innovative
Some uniques
Differentiated customer and product portfolio
Traumtanz 
31.10.23 50%
buy
Moderna Inc.

Start price
Target price
Perf. (%)
€183.12
18.01.23
€110.00
18.01.24
-61.97%
31.10.23

Normal challenges to pay loans and raise capital
Innovative
Some uniques
Differentiated customer and product portfolio
Traumtanz 
18.01.23 50%
buy
Moderna Inc.

Start price
Target price
Perf. (%)
€172.00
10.01.23
€180.00
10.01.24
6.47%
18.01.23

Normal challenges to pay loans and raise capital
Innovative
Some uniques
Differentiated customer and product portfolio
Traumtanz 
10.01.23 50%
buy
Moderna Inc.

Start price
Target price
Perf. (%)
€164.38
14.11.22
€175.00
14.11.23
9.00%
16.11.22

Normal challenges to pay loans and raise capital
Innovative
Some uniques
Differentiated customer and product portfolio
Traumtanz 
14.11.22 50%
buy
Moderna Inc.

Start price
Target price
Perf. (%)
€127.18
05.12.20
€130.00
2.20%
07.12.20

Normal challenges to pay loans and raise capital
Innovative
Some uniques
Differentiated customer and product portfolio
Traumtanz 
05.12.20 50%
buy
Moderna Inc.

Start price
Target price
Perf. (%)
€93.50
26.11.20
€100.00
12.81%
27.11.20

Normal challenges to pay loans and raise capital
Innovative
Some uniques
Differentiated customer and product portfolio
Traumtanz 
26.11.20 50%
buy
Moderna Inc.

Start price
Target price
Perf. (%)
€54.99
03.06.20
€60.00
04.06.20
-4.40%
04.06.20

Normal challenges to pay loans and raise capital
Innovative
Some uniques
Differentiated customer and product portfolio
Traumtanz 
03.06.20 50%
buy
Moderna Inc.

Start price
Target price
Perf. (%)
€58.34
15.05.20
€85.00
27.05.20
-4.61%
27.05.20

Normal challenges to pay loans and raise capital
Innovative
Some uniques
Differentiated customer and product portfolio
Traumtanz 
15.05.20 50%
buy
Moderna Inc.

Start price
Target price
Perf. (%)
€44.00
03.05.20
€70.00
14.05.20
33.00%
14.05.20

Normal challenges to pay loans and raise capital
Innovative
Some uniques
Differentiated customer and product portfolio
Traumtanz 
03.05.20 50%
buy
Moderna Inc.

Start price
Target price
Perf. (%)
€37.43
16.04.20
€50.00
21.04.20
32.71%
21.04.20

Normal challenges to pay loans and raise capital
Innovative
Some uniques
Differentiated customer and product portfolio
Traumtanz 
16.04.20 50%